• head_banner_01

Original Factory 2-Hydroxy-1-Naphthaldehyde - Semaglutide for Type 2 Diabetes – Gentolex

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

Every single member from our large efficiency revenue team values customers' wants and company communication for Altrenogest, Benzalkonium Chloride Antiseptic, Enzalutamide, First business, we learn each other. Further business, the trust is getting there. Our company always at your service at any time.
Original Factory 2-Hydroxy-1-Naphthaldehyde - Semaglutide for Type 2 Diabetes – Gentolex Detail:

Product Detail

Name  Semaglutide
CAS number  910463-68-2
Molecular formula  C187H291N45O59
Molecular weight  4113.57754
EINECS Number  203-405-2

Synonyms

Sermaglutide; Semaglutide fandachem; Semaglutide impurity; Sermaglutide USP/EP; semaglutide; Sermaglutide CAS 910463 68 2; Ozempic, 

Description

Semaglutide is a new generation of GLP-1 (glucagon-like peptide-1) analogs, and semaglutide is a long-acting dosage form developed based on the basic structure of liraglutide, which has a better effect in the treatment of type 2 diabetes. Novo Nordisk has completed 6 Phase IIIa studies of semaglutide injection, and submitted a new drug registration application for semaglutide weekly injection to the U.S. Food and Drug Administration (FDA) on December 5, 2016. A Marketing Authorization Application (MAA) was also submitted to the European Medicines Agency (EMA).

Compared with liraglutide, semaglutide has a longer aliphatic chain and increased hydrophobicity, but semaglutide is modified with a short chain of PEG, and its hydrophilicity is greatly enhanced. After PEG modification, it can not only bind closely to albumin, cover the enzymatic hydrolysis site of DPP-4, but also reduce renal excretion, prolong the biological half-life, and achieve the effect of long circulation.

Application

Semaglutide is a long-acting dosage form developed based on the basic structure of liraglutide, which is more effective in treating type 2 diabetes.

Bioactivity

Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC0113-0217) is a long-acting glucagon-like peptide 1 (GLP-1) analog, an agonist of GLP-1receptor, with a potential type 2 Therapeutic efficacy of diabetes mellitus (T2DM).

Quality System

In general, quality system and assurance is in place covering all stage of production of the finished product. Adequate manufacturing and control operations are performed in compliance with the approved procedures/ specifications. Change control and Deviation handling system is in place, and necessary impact assessment and investigation were conducted. Proper procedures are in place to ensure quality of product prior to release into the market.


Product detail pictures:

Original Factory 2-Hydroxy-1-Naphthaldehyde - Semaglutide for Type 2 Diabetes – Gentolex detail pictures

Original Factory 2-Hydroxy-1-Naphthaldehyde - Semaglutide for Type 2 Diabetes – Gentolex detail pictures


Related Product Guide:

We hold strengthening and perfecting our items and repair. At the same time, we get the job done actively to do research and progress for Original Factory 2-Hydroxy-1-Naphthaldehyde - Semaglutide for Type 2 Diabetes – Gentolex , The product will supply to all over the world, such as: Riyadh, Jamaica, Bangladesh, Now, with the development of internet, and the trend of internationalization, we've got decided to extend business to overseas market. With the propose of bringing more profits to oversea customers by providing directly abroad. So we have changed our mind, from home to abroad, hope to give our customers more profit, and looking forward to more chance to make business.
  • We are long-term partners, there is no disappointment every time, we hope to maintain this friendship later!
    5 Stars By Antonia from Vietnam - 2017.09.22 11:32
    This supplier's raw material quality is stable and reliable, has always been in accordance with the requirements of our company to provide the goods that quality meet our requirements.
    5 Stars By Yannick Vergoz from Bandung - 2018.09.12 17:18
    Write your message here and send it to us